-
Australian scientists study proves that NMN can strengthen bones
As we age, our bones become fragile and prone to fracture, and current treatments can only modestly increase bone density. This problem arises in large part because the underlying cause of osteoporosis (decreased bone mass and density) is unknown. Recently, Australian researchers published scient...Read more -
NMN alleviates radiation-induced intestinal fibrosis by modulating gut microbiota
Radiation-induced intestinal fibrosis is a common complication of long-term survivors after abdominal and pelvic radiotherapy. At present, there is no clinically available method to treat radiation-induced intestinal fibrosis. Studies have shown that nicotinamide mononucleotide (NMN) has the pote...Read more -
Research Express | Tsinghua University study shows NMN can treat inflammation
Macrophage activation is a pathogenic mechanism leading to chronic inflammation in the body , but persistent macrophage activation can lead to chronic inflammation and diseases such as insulin resistance and severe diseases such as atherosclerosis. PGE 2 , which mediates the inflammatory response...Read more -
Molecular Metabolism : The therapeutic effect of NMN supplementation on polycystic ovary syndrome
In recent years, with the increase of unhealthy lifestyles and the increasing social pressure of women, the incidence rate of polycystic ovary syndrome ( PCOS ) has become more and more obvious. Foreign studies have shown that the incidence of polycystic ovary syndrome (PCOS) in women of childbea...Read more -
Clinical study on human body: NMN can effectively reduce triglyceride level
Triglyceride (TG) is a kind of fat with a large content in human body. All organs and tissues of human body can use triglyceride to provide energy, and the liver can synthesize triglyceride and store it in the liver. If the triglyceride is increased, it means that the liver accumulates too much f...Read more -
FDA approves ibrutinib for the treatment of chronic graft-versus-host disease ( cGVHD ) in children
On August 24, 2022, the U.S. Food and Drug Administration (FDA) approved ibrutinib for the treatment of pediatric patients older than 1 year with chronic graft-versus-host disease ( cGVHD ) who are receiving After failure of 1- or multi-line systemic therapy . The approved indication is mainly fo...Read more -
A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction
Nicotinamide adenine dinucleotide (NAD+) is a research hotspot of scientists at home and abroad. Most scientists believe that the level of NAD+ is closely related to age-related chronic diseases, such as cancer, obesity, hypertension and diabetes. Keratinocyte carcinoma ...Read more -
New discovery : NMN can improve fertility problems caused by obesity
The oocyte is the beginning of human life, it is an immature egg cell that eventually matures into an egg. However, oocyte quality decreases as women age or due to factors such as obesity , and low-quality oocytes are the main cause of low fertility in obese women. Howev...Read more -
Scientific research express | Spermidine can treat hypopigmentation
Hypopigmentation is a skin disease, mainly manifested by melanin reduction. Common symptoms include vitiligo, albinism and hypopigmentation after skin inflammation. At present, the main treatment for hypopigmentation is oral medicine, but oral medicine will cause skin at...Read more -
Big News! SyncoZymes (Shanghai) Co., Ltd. The world’s first NMN raw material passed FDA NDI certification.
After strict review by the professional committee of the US FDA (US Food and Drug Administration) authoritative organization, on May 17, 2022, SyncoZymes (Shanghai) Co., Ltd. officially received the FDA's confirmation letter (AKL): NMN raw material successfully passed ND...Read more -
Research progress on enzymatic synthesis of potential precursors of Clenbuterol in cooperation between Norwegian University of Science and Technology and Shangke Biomedical
Clenbuterol, is a β2-adrenergic agonist (β2-adrenergic agonist), similar to ephedrine (Ephedrine), is often used clinically to treat chronic obstructive pulmonary disease (COPD), It is also used as a bronchodilator to relieve acute exacerbations of asthma. In the early 1...Read more -
Zhejiang Syncozymes Biopharmaceutical Co., Ltd. The enzyme catalysis project passed the preliminary review of the key research and development plan of Zhejiang Province
In August 2020, the “Bio-enzyme Library Development and Green Catalytic Synthesis Application” project of Zhejiang Shangke Biopharmaceutical Co., Ltd. passed the preliminary review of the Zhejiang Provincial Key R&D Program of the Zhejiang Provincial Department of Science and Tech...Read more
